Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00928330 |
|---|---|
| Brief Title: | Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy |
| First Submitted : | June 23, 2009 |
| First Submitted that Met QC Criteria : | June 24, 2009 |
| First Posted : | June 25, 2009 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 1, 2016 |
| Last Update Posted : | November 2, 2016 (Estimate) |